Preface |
|
ix | |
Acknowledgments |
|
xi | |
|
|
1 | (20) |
|
Forward and side (orthogonal) scatter |
|
|
2 | (2) |
|
Flow cytometry of peripheral blood and bone marrow -- gating strategy |
|
|
4 | (2) |
|
Flow cytometry of lymph node and other 'solid' tissues -- exclusion of non-viable cells |
|
|
6 | (9) |
|
Intensity of staining and co-expression of antigens |
|
|
15 | (5) |
|
Aberrant expression of antigens |
|
|
20 | (1) |
|
Identification of clonal B cells |
|
|
21 | (14) |
|
Reactive lymph node (follicular hyperplasia) |
|
|
21 | (1) |
|
|
21 | (6) |
|
Clonal B cells with no detectable surface immunoglobulins |
|
|
27 | (7) |
|
Additional markers in B-cell lymphomas |
|
|
34 | (1) |
|
Identification of abnormal T cells |
|
|
35 | (16) |
|
Forward scatter and pan-T antigen expression |
|
|
35 | (3) |
|
|
38 | (9) |
|
Additional markets in T-cell lymphoproliferations |
|
|
47 | (2) |
|
Mature T-cell disorders versus precursor T-lymphoblastic leukemia/lymphoma |
|
|
49 | (2) |
|
|
51 | (14) |
|
|
52 | (7) |
|
|
59 | (2) |
|
Thymocytes versus precursor T-lymphoblastic lymphoma |
|
|
61 | (4) |
|
|
65 | (8) |
|
Flow cytometry limitations |
|
|
73 | (8) |
|
|
81 | (30) |
|
|
81 | (1) |
|
|
82 | (1) |
|
|
82 | (1) |
|
|
83 | (1) |
|
|
83 | (1) |
|
|
83 | (7) |
|
|
90 | (1) |
|
|
90 | (1) |
|
|
90 | (1) |
|
|
91 | (1) |
|
|
91 | (2) |
|
|
93 | (1) |
|
|
93 | (1) |
|
|
93 | (1) |
|
|
93 | (3) |
|
|
96 | (1) |
|
|
96 | (1) |
|
|
96 | (2) |
|
|
98 | (1) |
|
|
98 | (1) |
|
|
99 | (1) |
|
|
99 | (1) |
|
|
99 | (1) |
|
|
100 | (1) |
|
|
100 | (1) |
|
|
100 | (4) |
|
|
104 | (1) |
|
|
104 | (1) |
|
|
104 | (2) |
|
|
106 | (1) |
|
|
106 | (1) |
|
|
106 | (1) |
|
|
106 | (1) |
|
|
106 | (1) |
|
|
106 | (1) |
|
|
106 | (5) |
|
B-cell lymphoproliferations |
|
|
111 | (44) |
|
B-chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
|
112 | (15) |
|
B-cell prolymphocytic leukemia |
|
|
127 | (3) |
|
Lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia |
|
|
130 | (1) |
|
Marginal zone B-cell lymphoma |
|
|
131 | (3) |
|
|
134 | (2) |
|
|
136 | (4) |
|
|
140 | (1) |
|
Diffuse large B-cell lymphoma |
|
|
141 | (2) |
|
Primary effusion lymphoma |
|
|
143 | (2) |
|
|
145 | (6) |
|
|
151 | (4) |
|
Peripheral (mature/post-thymic) T-cell lymphoproliferations |
|
|
155 | (26) |
|
T-cell prolymphocytic leukemia |
|
|
156 | (1) |
|
Large granular lymphocyte leukemia |
|
|
156 | (2) |
|
Adult T-cell leukemia/lymphoma |
|
|
158 | (1) |
|
Aggressive NK-cell leukemia |
|
|
158 | (1) |
|
Extranodal NK/T-cell lymphoma, nasal type |
|
|
158 | (2) |
|
Enteropathy-type T-cell lymphoma |
|
|
160 | (1) |
|
Hepatosplenic T-cell lymphoma |
|
|
160 | (1) |
|
Peripheral T-cell lymphoma, unspecified |
|
|
160 | (12) |
|
Angioimmunoblastic T-cell lymphoma |
|
|
172 | (1) |
|
Anaplastic large cell lymphoma |
|
|
172 | (4) |
|
Cutaneous T-cell lymphomas |
|
|
176 | (5) |
|
|
181 | (40) |
|
|
181 | (29) |
|
Precursor B-lymphoblastic leukemia/lymphoma |
|
|
210 | (2) |
|
Precursor T-lymphoblastic leukemia/lymphoma |
|
|
212 | (3) |
|
Blastic NK-cell lymphoma (DC2 acute leukemia; plasmacytoid dendritic cell leukemia) |
|
|
215 | (2) |
|
Extramedullary myeloid tumor (granulocytic sarcoma) |
|
|
217 | (2) |
|
Biphenotypic acute leukemia |
|
|
219 | (2) |
|
Myelodysplastic syndromes and chronic myeloproliferative disorders |
|
|
221 | (16) |
|
Myelodysplastic syndromes |
|
|
221 | (6) |
|
Chronic myelomonocytic leukemia |
|
|
227 | (1) |
|
Chronic myeloproliferative disorders |
|
|
227 | (10) |
Abbreviations |
|
237 | (2) |
References |
|
239 | (24) |
Index |
|
263 | |